NDC 0049-2512

Cardura

Doxazosin

Cardura is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Roerig. The primary component is Doxazosin Mesylate.

Product ID0049-2512_36f959e8-2dfe-423b-b8ce-9480c0577d81
NDC0049-2512
Product TypeHuman Prescription Drug
Proprietary NameCardura
Generic NameDoxazosin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-10-19
Marketing CategoryNDA /
Application NumberNDA019668
Labeler NameRoerig
Substance NameDOXAZOSIN MESYLATE
Active Ingredient Strength2 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0049-2512-10

100 TABLET in 1 BOTTLE (0049-2512-10)
Marketing Start Date2021-10-19
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cardura" or generic name "Doxazosin"

NDCBrand NameGeneric Name
0049-2040Carduradoxazosin
0049-2080Carduradoxazosin
0049-2410Carduradoxazosin
0049-2512Carduradoxazosin
0049-2614Carduradoxazosin
0049-2710Carduradoxazosin mesylate
0049-2720Carduradoxazosin mesylate
0049-2750Carduradoxazosin mesylate
0049-2760Carduradoxazosin mesylate
0049-2770Carduradoxazosin mesylate
0049-2780Carduradoxazosin mesylate

Trademark Results [Cardura]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CARDURA
CARDURA
73528813 1360101 Live/Registered
PFIZER INC.
1985-03-25
CARDURA
CARDURA
72144546 0747425 Live/Registered
Shell Oil Comany
1962-05-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.